Related Experiment Videos
Identifying organization-level features important to patient outcomes in cancer care: qualitative interview results
Jennifer Elston Lafata1, Soohyun Hwang2, Erica S Breslau3
1University of North Carolina Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center, 2214 Kerr Hall, Campus Box 7573, Chapel Hill, NC, 27599, USA. jel@email.unc.edu.
Background:
Addressing quality and equity requires understanding organization-level features that affect patient outcomes. Using cancer care as the context, we aimed to identify organization-level features important to patient-level outcomes and assess the feasibility of including them in clinical data warehouses.
Methods:
In-depth interviews were conducted with 12 experts, including academicians with expertise in organizational theory and implementation science, oncology practitioners, and clinical data warehouse developers. Members of the research team developed a semi-structured interview guide to identify organization-level features perceived as important to patient outcomes, and the measurability and obtainability of identified features. Interviews were audio-recorded and transcribed verbatim. De-identified transcript data were organized using NVivo 12 and analyzed using thematic analyses.
Results:
Analysis revealed key organization-level features important to care quality, including leadership structure and culture, quality monitoring processes, external incentives, and support service provision. Respondents highlighted the importance of intentionality to equity, and how many of the same organization features affecting quality also affect equity. Some features were deemed readily knowable, while others presented measurement challenges to extract from existing data resources or to collect de novo. Given their ownership of the data in the US, collaboration with healthcare organizations will be essential for advancing organization-level measurement in the US.
Conclusions:
Understanding organization-level features is vital for enhancing care quality and promoting equity in cancer care and otherwise. Leveraging publicly available information and fostering partnerships between healthcare organizations and researchers could facilitate the compilation of relevant data. External incentives and measurement development initiatives could afford further advancement. Findings contribute to the understanding of organization-level determinants of cancer care quality and equity, offering practical avenues for research, data collection, and improved care and outcomes.
Related Concept Videos
01:21Cancer Survival Analysis
01:27Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:13Patient-centered Care
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:27Ethical Issues
Ethical Concerns in Healthcare:
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...